Literature DB >> 9153304

Differential in vivo activation of the class II and class III snRNA genes by the POU-specific domain of Oct-1.

S Murphy1.   

Abstract

Many snRNA genes contain binding sites for the ubiquitous transcription factor Oct-1. In vitro studies have shown that this factor potentiates binding of an essential transcription factor (PTF) to the proximal sequence element (PSE) of snRNA genes, and activates transcription. Using Gal4 fusion proteins, I show here that the POU-specific region of the DNA-binding domain of Oct-1 is sufficient both to potentiate PTF binding in vitro and to transactivate pol II- and pol III-dependent snRNA genes in vivo . A single amino acid change in this domain abrogates both activation and interaction with PTF. The N- and C-terminal regions of Oct-1 also activate transcription of both classes of snRNA genes. Wild-type levels of Pol II-dependent U2 expression require all activation domains, whereas efficient activation of the pol III-dependent 7SK and U6 genes is effected by the POU-specific domain alone. These results indicate that contacts between PTF and amino acids in the POU-specific domain of Oct-1 are critical for efficient transactivation of snRNA genes in vivo. The POU-specific domain of Oct-2A also activates these genes, but the N- and C-terminal domains are relatively inactive.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9153304      PMCID: PMC146712          DOI: 10.1093/nar/25.11.2068

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  43 in total

1.  Promoter-selective activation domains in Oct-1 and Oct-2 direct differential activation of an snRNA and mRNA promoter.

Authors:  M Tanaka; J S Lai; W Herr
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

2.  The cloned RNA polymerase II transcription factor IID selects RNA polymerase III to transcribe the human U6 gene in vitro.

Authors:  S M Lobo; J Lister; M L Sullivan; N Hernandez
Journal:  Genes Dev       Date:  1991-08       Impact factor: 11.361

Review 3.  Immunoglobulin gene transcription.

Authors:  L M Staudt; M J Lenardo
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

4.  A 7 bp mutation converts a human RNA polymerase II snRNA promoter into an RNA polymerase III promoter.

Authors:  S M Lobo; N Hernandez
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

5.  Role for the amino-terminal region of human TBP in U6 snRNA transcription.

Authors:  V Mittal; N Hernandez
Journal:  Science       Date:  1997-02-21       Impact factor: 47.728

Review 6.  Octamania: the POU factors in murine development.

Authors:  H R Schöler
Journal:  Trends Genet       Date:  1991-10       Impact factor: 11.639

7.  Oct-1 and Oct-2 potentiate functional interactions of a transcription factor with the proximal sequence element of small nuclear RNA genes.

Authors:  S Murphy; J B Yoon; T Gerster; R G Roeder
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

8.  Nuclear factor I can functionally replace transcription factor Sp1 in a U2 small nuclear RNA gene enhancer.

Authors:  L Janson; P Weller; U Pettersson
Journal:  J Mol Biol       Date:  1989-01-20       Impact factor: 5.469

9.  Both Oct-1 and Oct-2A contain domains which can activate the ubiquitously expressed U2 snRNA genes.

Authors:  J Yang; M M Müller-Immerglück; K Seipel; L Janson; G Westin; W Schaffner; U Pettersson
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

10.  Identification of transcription factors required for the expression of mammalian U6 genes in vitro.

Authors:  R Waldschmidt; I Wanandi; K H Seifart
Journal:  EMBO J       Date:  1991-09       Impact factor: 11.598

View more
  12 in total

1.  Intergenic transcription in the human beta-globin gene cluster.

Authors:  K E Plant; S J Routledge; N J Proudfoot
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

2.  Transcription of the human U2 snRNA genes continues beyond the 3' box in vivo.

Authors:  P Cuello; D C Boyd; M J Dye; N J Proudfoot; S Murphy
Journal:  EMBO J       Date:  1999-05-17       Impact factor: 11.598

3.  Activator recruitment by the general transcription machinery: X-ray structural analysis of the Oct-1 POU domain/human U1 octamer/SNAP190 peptide ternary complex.

Authors:  Stacy Hovde; Craig S Hinkley; Katie Strong; Aimee Brooks; Liping Gu; R William Henry; James Geiger
Journal:  Genes Dev       Date:  2002-11-01       Impact factor: 11.361

4.  A tandem array of minimal U1 small nuclear RNA genes is sufficient to generate a new adenovirus type 12-inducible chromosome fragile site.

Authors:  Z Li; A D Bailey; J Buchowski; A M Weiner
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  The distal elements, OCT and SPH, stimulate the formation of preinitiation complexes on a human U6 snRNA gene promoter in vitro.

Authors:  G R Kunkel; J D Hixson
Journal:  Nucleic Acids Res       Date:  1998-03-15       Impact factor: 16.971

6.  The microsatellite sequence (CT)n x (GA)n promotes stable chromosomal integration of large tandem arrays of functional human U2 small nuclear RNA genes.

Authors:  A D Bailey; T Pavelitz; A M Weiner
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

7.  Two distinct domains in Staf to selectively activate small nuclear RNA-type and mRNA promoters.

Authors:  C Schuster; A Krol; P Carbon
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

8.  The activation function 2 domain of hepatic nuclear factor 4 is regulated by a short C-terminal proline-rich repressor domain.

Authors:  V P Iyemere; N H Davies; G G Brownlee
Journal:  Nucleic Acids Res       Date:  1998-05-01       Impact factor: 16.971

9.  The C-terminal domain of pol II and a DRB-sensitive kinase are required for 3' processing of U2 snRNA.

Authors:  Joanne E Medlin; Patricia Uguen; Alice Taylor; David L Bentley; Shona Murphy
Journal:  EMBO J       Date:  2003-02-17       Impact factor: 11.598

10.  Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study.

Authors:  Krzysztof Pluta; William Diehl; Xian-Yang Zhang; Robert Kutner; Agnieszka Bialkowska; Jakob Reiser
Journal:  BMC Biotechnol       Date:  2007-07-16       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.